Osaic Holdings
ADAP

Osaic Holdings’s Adaptimmune Therapeutics ADAP Stock Holding History

Osaic Holdings’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,058
Closed -$198 – 7822
2025
Q3 		$198 Sell
2,058
-88,000
-98% -$12.1K ﹤0.01% 7695
2025
Q2 		$20.7K Buy
90,058
+25,000
+38% +$6.67K ﹤0.01% 5681
2025
Q1 		$13K Buy
65,058
+38,500
+145% +$19.9K ﹤0.01% 5642
2024
Q4 		$14.3K Buy
26,558
+11,300
+74% +$8.23K ﹤0.01% 5564
2024
Q3 		$14.5K Hold
15,258
– – ﹤0.01% 5573
2024
Q2 		$14.8K Sell
15,258
-4,000
-21% -$4.39K ﹤0.01% 5545
2024
Q1 		$30.4K Buy
19,258
+13,000
+208% +$15.7K ﹤0.01% 5090
2023
Q4 		$4.96K Sell
6,258
-4,200
-40% -$2.37K ﹤0.01% 6180
2023
Q3 		$8.16K Buy
10,458
+8,200
+363% +$6.88K ﹤0.01% 6036
2023
Q2 		$2.09K Buy
2,258
+1,058
+88% +$1.26K ﹤0.01% 6651
2023
Q1 		$1.31K Hold
1,200
– – ﹤0.01% 6870
2022
Q4 		$2K Sell
1,200
-50
-4% -$81 ﹤0.01% 6602
2022
Q3 		$1K Hold
1,250
– – ﹤0.01% 6922
2022
Q2 		$2K Hold
1,250
– – ﹤0.01% 6832
2022
Q1 		$2K Hold
1,250
– – ﹤0.01% 6838
2021
Q4 		$5K Buy
1,250
+200
+19% +$910 ﹤0.01% 6601
2021
Q3 		$5K Buy
1,050
+1,000
+2,000% +$4.49K ﹤0.01% 6507
2021
Q2 		$0 Buy
+50
New +$243 ﹤0.01% 6966
2020
Q4 		– Sell
-12,676
Closed -$101K – 6369
2020
Q3 		$101K Buy
+12,676
New +$111K ﹤0.01% 3825
2020
Q2 		– Sell
-1,000
Closed -$3K – 6079
2020
Q1 		$3K Buy
+1,000
New +$3.32K ﹤0.01% 5508

Other funds holding ADAP

JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Osaic Holdings's ADAP Position: Q4 2025 in Review

Osaic Holdings sold out of Adaptimmune Therapeutics (ADAP) in Q4 2025, closing a stake of 2,058 shares — an estimated $198 sold.

Osaic Holdings first reported a position in ADAP in Q1 2020 and held it in 20 quarters. The position peaked at $101K in Q3 2020. 10 funds tracked by Wall St. Rank hold ADAP as of Q4 2025.

  • Osaic Holdings reported no remaining Adaptimmune Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 2,058 Adaptimmune Therapeutics shares in Q4 2025, an estimated $198.
  • Osaic Holdings first reported a position in Adaptimmune Therapeutics in Q1 2020 and held it in 20 quarters.
  • Osaic Holdings's Adaptimmune Therapeutics position peaked at $101K in Q3 2020.
  • 10 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.